Bioceramics Market

Updated on : October 10, 2024

Bioceramics Market

The bioceramics market was valued at USD 7.4 billion in 2023 and is projected to reach USD 10.2 billion by 2028, growing at 6.7% cagr from 2023 to 2028. Bioceramics is a relatively new field; it did not exist until the beginning of the 1970s. The commercialization of bioceramics began to gain momentum in the late 20th century. The commercialization of bioceramics started with the introduction of alumina (aluminum oxide) and zirconia (zirconium dioxide) ceramics for orthopedic implants, such as hip replacements. Companies like Zimmer Biomet, DePuy Synthes, and Stryker began producing and marketing ceramic-based implants for joint replacement surgeries. With advancements in materials science and manufacturing technologies, the commercialization of bioceramics expanded further in the 1900s. Companies invested in research and development to improve the performance, biocompatibility, and longevity of bioceramic products. The commercialization of bioceramics has continued to evolve in the 21st century. Companies are increasingly investing in innovative bioceramic technologies, such as additive manufacturing (3D printing), surface modifications to enhance bioactivity, and nanoscale engineering for improved properties.

The major applications of bioceramics in today’s day and age include orthopedic, dental, and other biomedical applications.

Attractive Opportunities in Bioceramics Market Trends

To know about the assumptions considered for the study, Request for Free Sample Report

Bioceramics Market Dynamics

Driver: Biocompatibility

One of the major drivers of bioceramics in the medical market is aging population. As the global population ages, there is a growing demand for medical solutions to address age-related conditions such as osteoarthritis, osteoporosis, and dental problems. Increasing awareness among patients and healthcare professionals about the benefits of bioceramic materials, such as their biocompatibility, durability, and ability to integrate with natural tissues, is driving demand for bioceramic products in various medical applications.

Restraint: Long-Term Performance and Durability Concerns

While bioceramic materials are known for their biocompatibility and resistance to corrosion, concerns about long-term performance and durability of implants and devices may arise. Although there has been significant progress in the development of bioceramic materials, the range of available materials is still relatively limited compared to other biomaterials. This limitation may restrict the suitability of bioceramics for certain medical applications or patient populations, limiting market opportunities. The production of bioceramic materials often involves sophisticated manufacturing processes, specialized equipment, and quality control measures to ensure biocompatibility and performance. These factors contribute to higher manufacturing costs, which can limit market growth, particularly in price-sensitive markets or for patients without adequate healthcare coverage.

Opportunity: Emerging markets and medical tourism along with sustainable nature.

Growing healthcare infrastructure in emerging markets present opportunities for market expansion in regions such as Asia-Pacific, Latin America, and the Middle East. Additionally, medical tourism trends drive demand for high-quality bioceramic implants and devices in countries offering advanced healthcare services at competitive prices like India, China and Malaysia. Bioceramic materials play a critical role in regenerative medicine and stem cell therapy by providing scaffolds for cell attachment, proliferation, and differentiation. Opportunities exist for developing bioceramic-based products and therapies that harness the regenerative potential of stem cells for tissue repair and organ regeneration.

Challenge: Long term durability and cost considerations

Ensuring the long-term durability, stability, and performance of bioceramic implants and devices over the patient's lifespan is critical for minimizing the risk of implant failure, revision surgeries, and associated healthcare costs. The cost of bioceramic implants and devices, including manufacturing costs, material expenses, and associated healthcare expenditures, can be significant compared to alternative biomaterials. Challenges may arise in achieving cost-effective solutions that balance performance, quality, and affordability while meeting healthcare budget constraints.

Bioceramics Market Ecosystem

Based on the material type, the calcium phosphate segment is estimated to be the fastest-growing type during the forecast period in terms of value.

Calcium phosphate is often combined with phosphopeptide to form products such as recaldent and tooth mousse, which are applied directly to teeth to aid in remineralization and reduce sensitivity. The material has shown significant effects on biomineralization and has promising applications in drug delivery and bone therapy. Its unique properties, such as high capacity for drug loading and controlled release, make it suitable for these applications.

Based on the type, the bio-active segment is estimated to be the fastest-growing type during the forecast period, in terms of value.

When implanted, bioactive ceramics stimulate healing and trigger the response of the tissue system. Bio-active ceramics are largely used to repair bone damage owing to their compatibility with living bone. These ceramics are osteoconductive and form a bone-like apatite through a chemical reaction with surrounding body fluids. These ceramics interact with the body so that tissue bonding and further integration into the body occur over time.

Based on application, the orthopedic application segment is anticipated to register the second-highest CAGR in bioceramics market.

Bioceramics are commonly used in orthopedic applications due to several advantageous properties that make them suitable for this field. Bioceramics are biocompatible materials, meaning they are well-tolerated by the body and elicit minimal immune response or rejection when implanted into living tissue. This property is crucial for orthopedic implants, as they need to integrate seamlessly with bone tissue without causing adverse reactions. Some bioceramics are bio-active, meaning they have the ability to chemically bond with bone tissue and stimulate bone regeneration.

Europe to be the second-largest market for Bioceramics during the forecast period, in terms of value.

The European bioceramics market is a mature market. Currently, bioceramics are increasingly used to produce orthopedic and dental implants. There is a forecasted growth of opportunities in the medical industry in the European market due to the biocompatible nature of the material and increasing change in the consumer behavior.

To know about the assumptions considered for the study, download the pdf brochure

Bioceramics Market Players

The bioceramic market is dominated by a few globally established players,Coorstek, Inc . (US), Kyocera Corporation (Japan), Morgan Advanced Materials Plc (UK), CeramTec GmbH (Germany), Tosoh Ceramics Co., Ltd. (Japan), Institut Straumann AG (Switzerland), Berkeley Advanced Biomaterials Inc. (US), DSM (Netherlands), CTL Amedica (US), and 3M (US). among others, are the main producers in the global market.

These companies are attempting to establish themselves in the bioceramic market by employing a range of inorganic and organic approaches. A thorough competitive analysis of these major bioceramic market participants is included in the research, along with information on their company profiles, most recent advancements, and important market strategies.

Read More: Bioceramics Companies

Bioceramics Market Report Scope

The study categorizes the bioceramics market based on Type, Application, and Region.

Bioceramics Market by Type

• Bio-inert
• Bio-active
• Bio-resorbable

Bioceramics Market by Material Type

• Aluminum Oxide
• Zirconia
• Calcium Phosphate
• Calcium Sulfate
• Bio-active Glass
• Others (Carbon, Silicon Nitride, Boron Nitride, Barium Titanate)

Bioceramics Market by Application

• Orthopedic
• Dental
• Bio-medical

Bioceramics Market by Form

• Powder
• Liquid

Bioceramics Market by Region

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa

Recent Developments in Bioceramics Market

• In January 2021, The CeramTec Group had announced the acquisition of the Swiss specialist for ceramic dental implants, Dentalpoint AG.
• In May 2021, CeramTec GmbH launched BIOLOX Contura, femoral heads that retain the outer diameter profile of conventional implants and incorporate a contoured shoulder with a lesser radius.
• In August 2021, Kyocera Corporation announced that it has entered into an agreement with Osteon Digital Japan Co., Ltd. for continuous sales transactions, and will begin sales of customized dental prostheses for implants utilizing Implant Solutions digital technology starting in September 2021.
• In December 2021, Tosoh Ceramics Co., Ltd. introduced Zgaia, a next-gen, higher grade zirconia powder developed to achieve a perfect balance of high fracture toughness and high bending strength that opens a new world of applications.
• In June 2022, CoorsTek, announced the expansion of the Advanced Materials Processing (AMP) center at its Benton, Arkansas facility.
• In August 2023, Smith + Nephew launched OR3O Dual Mobility System in India for use in primary and revision hip arthroplasty.
• In September 2023, Straumann Group acquired AlliedStar to complement its intraoral scanner portfolio across different price points and expand market access of its digital solutions.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst